What is the current market size?

The Interventional Neuroradiology market size was valued at USD 1.2 billion in 2023, driven by expanding applications in stroke and aneurysm treatment.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, with the future outlook fueled by technological advancements and aging populations.

What are the key drivers?

Key drivers include rising incidence of neurological disorders, adoption of minimally invasive procedures, and enhanced imaging technologies.

What challenges does the market face?

Challenges include high procedural costs, reimbursement limitations, and the need for specialized training for complex interventions.

Which regions are market leaders?

North America dominates due to advanced healthcare infrastructure, while Asia-Pacific shows rapid growth from improving medical facilities.

Who are the top companies?

Leading companies include Medtronic, Stryker, and Siemens Healthineers, focusing on innovation and strategic collaborations.

What future opportunities exist?

Opportunities lie in expanding applications for pediatric neurology, AI integration, and emerging markets with growing healthcare access.

How is technology impacting the market?

Advancements in robotic-assisted systems, 3D imaging, and real-time navigation are enhancing procedural accuracy and adoption rates.

What is the regulatory landscape?

Regulatory approval processes are stringent, emphasizing safety and efficacy, but supportive policies in key regions are accelerating innovation.

Interventional Neuroradiology - Strategic Insights: Analysis 2025 and Forecasts 2033

Interventional Neuroradiology by Application (Hospital, Ambulatory Surgical Centers), by Types (Cerebral Aneurysms, Intra-Cranial Tumors, Acute Strokes, Other Diseases), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1800 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1800 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Interventional Neuroradiology Market Overview

The Interventional Neuroradiology market encompasses minimally invasive, image-guided procedures to diagnose and treat neurological conditions, such as aneurysms, strokes, and vascular malformations. As a critical subset of neurology and radiology, it leverages advanced imaging technologies like CT, MRI, and angiography to improve patient outcomes and reduce recovery times. The market is driven by rising prevalence of cerebrovascular diseases, technological innovations in endovascular devices, and a shift toward less invasive treatment modalities. With the Interventional Neuroradiology market size projected to expand significantly, stakeholders are prioritizing growth outlook strategies amid evolving clinical guidelines and healthcare digitization trends.

In 2026, the global Interventional Neuroradiology market is estimated at USD 4.1 billion, reflecting a CAGR of 7.8% from 2026 to 2033. Key macro drivers include an aging population with comorbidities and increasing adoption of robotic-assisted systems for procedural precision. Regulatory approvals for next-generation flow diverters and embolic agents are accelerating therapeutic options. North America remains the largest regional market due to high healthcare spending, while Asia-Pacific is the fastest-growing region, fueled by expanding neurology centers and improving reimbursement policies. Competitive intensity is rising, with manufacturers and hospitals collaborating to integrate AI-driven imaging analytics, reshaping the market forecast for the decade ahead.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.80 billion
Revenue forecast in 2033	3.21 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Balt Extrusion; Merit Medical; Terumo; Medtronic; Penumbra; Stryker; DePuy; Boston Scientific; W. L. Gore; MicroPort
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of neurological disorders such as stroke and aneurysms is fueling demand for Interventional Neuroradiology market procedures, supported by aging populations and improved diagnostic accuracy.

Advancements in minimally invasive technologies, such as robotic-assisted systems and AI-integrated imaging, are enhancing procedural precision and reducing recovery times, driving adoption in the Interventional Neuroradiology market size.

Restraints2 items

High costs of advanced interventional devices and procedures limit accessibility, particularly in low- and middle-income countries, constraining Interventional Neuroradiology market expansion.

Stringent regulatory requirements for device approvals and clinical trials pose delays in market entry, increasing R&D costs for new therapies or equipment.

Opportunities2 items

Growing healthcare investments in emerging economies, coupled with telemedicine-enabled training programs, are unlocking untapped demand in the Interventional Neuroradiology market.

Partnerships between device manufacturers and hospitals to co-develop cost-effective solutions could accelerate innovation and improve affordability, boosting the Interventional Neuroradiology market size.

Challenges2 items

The technical complexity of procedures requires highly trained specialists, creating a shortage of skilled professionals and limiting market scalability.

Inconsistent reimbursement policies across regions create financial uncertainty for providers, hindering the growth forecast of the Interventional Neuroradiology market in cost-sensitive healthcare systems.

Market Segmentation

Loading chart…

Interventional Neuroradiology segmentation by Application reveals two critical subcategories: Cerebrovascular Diseases and Spinal Interventions. Cerebrovascular Diseases, including stroke and cerebral aneurysm treatments, dominate the market due to the high prevalence of neurological disorders and advancements in endovascular techniques. Spinal Interventions, such as vertebroplasty and spinal tumor embolization, represent a growing segment driven by aging populations and increased spinal trauma cases. These applications collectively define the market’s scope, with Cerebrovascular Diseases accounting for ~65% of the market size, reflecting the demand for minimally invasive alternatives to traditional neurosurgery.

In Types segmentation, Interventional Neuroradiology is divided into Diagnostic and Therapeutic procedures. Diagnostic procedures, such as Diagnostic Angiography and Image-Guided Biopsies, focus on identifying neurological pathologies through imaging. Therapeutic procedures, including Aneurysm Coiling and Embolization, address vascular abnormalities and tumors. The Therapeutic segment holds a larger share (~60% of the market) due to the rising adoption of catheter-based treatments for acute conditions like hemorrhagic stroke. This duality in market taxonomy underscores the balance between diagnostic precision and treatment innovation, with technological advancements in imaging and device design driving growth in both categories.

Interventional Neuroradiology Segmentation Breakdown8 items

Application

Hospital

Ambulatory Surgical Centers

Types

Cerebral Aneurysms

Intra-Cranial Tumors

Acute Strokes

Other Diseases

Regional Insights

Loading chart…

The Interventional Neuroradiology market growth is anchored by North America, which dominates with 40% of the global share, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust R&D investments. The region benefits from favorable reimbursement policies and a mature ecosystem of key players, enabling consistent innovation. Europe follows with 30%, fueled by a strong regulatory framework, aging demographics, and cross-border collaborations enhancing diagnostic precision. Emerging markets in the Asia Pacific region (15%) are the fastest-growing, propelled by rising healthcare investments, urbanization, and increasing prevalence of cerebrovascular diseases. Latin America (10%) sees incremental progress due to improving public-private infrastructure and growing awareness, while the Middle East & Africa (5%) experience fragmented growth, supported by government-led healthcare modernization and rising disposable incomes. The regional forecast underscores Asia Pacific’s potential, with expanding access to neurointerventional services and a growing middle-class population driving demand.

Key Drivers by Region5 items

North America: Advanced healthcare ecosystem, high procedural adoption, and R&D investments.

Europe: Regulatory harmonization, aging population, and cross-border medical collaboration.

Asia Pacific: Rising healthcare expenditure, urbanization, and disease prevalence.

Latin America: Infrastructure upgrades and growing neurology service accessibility.

Middle East & Africa: Government healthcare initiatives and urban economic expansion.

Competitive Landscape

The Interventional Neuroradiology competitive landscape is moderately consolidated, with a mix of global leaders and specialized regional players. Key competitive dynamics are shaped by product innovation cycles, regulatory approvals for advanced neurovascular devices, and strategic distribution partnerships. Pricing strategies vary between premium segments targeting high-margin hospitals and cost-optimized offerings in emerging markets. Certifications such as CE Mark and FDA clearance act as critical entry barriers, while differentiation hinges on proprietary technologies like thrombectomy systems or intracranial stents. The market remains highly sensitive to R&D investments, with companies prioritizing next-generation embolic materials and minimally invasive solutions.

Competitive differentiation is driven by R&D focus areas, channel specialization, and geographic expansion tactics. Companies face margin pressures from payor reimbursement constraints and rising compliance costs under evolving medical device regulations. Strategic initiatives include cross-licensing agreements to bypass IP roadblocks, joint ventures with academic medical centers for clinical trials, and vertical integration of raw material suppliers to mitigate supply chain risks. Localized manufacturing hubs are increasingly adopted to reduce lead times in Asia-Pacific and Latin America. Technology leadership in AI-assisted navigation systems and biocompatible polymers is becoming a key battleground for market share.

Medtronic: Innovation pipeline in endovascular aneurysm repair devices

Stryker: Regional expansion through acquisitions in emerging markets

Boston Scientific: OEM tie-ups for neurovascular coil manufacturing

Terumo: Premium pricing for thrombectomy catheter systems

Penumbra: R&D partnerships for stroke treatment platforms

MicroPort: Local manufacturing to serve China’s neurointervention market

Key Interventional Neuroradiology Companies10 items

Balt Extrusion

Merit Medical

Terumo

Medtronic

Penumbra

Stryker

DePuy

Boston Scientific

W. L. Gore

MicroPort

Market Ecosystem

The Interventional Neuroradiology ecosystem spans upstream technology and component suppliers, midstream device and system manufacturers, and downstream healthcare providers. Value is generated through precision diagnostics and minimally invasive treatments, with stakeholders collaborating to enhance procedural efficacy and patient outcomes.

Raw material/component suppliers – supply polymers, metals, and imaging sensors for device fabrication

OEMs/Manufacturers – design and produce interventional catheters, guidewires, and imaging systems

Technology providers – develop AI-driven imaging algorithms and real-time navigation software

System integrators – customize equipment configurations for hospital radiology suites

Distributors/Channel partners – facilitate equipment and consumables procurement for clinical facilities

Service providers/After-sales – ensure device maintenance and regulatory compliance through calibration services

End users – neurointerventional radiologists perform procedures in acute stroke and aneurysm treatment

Control points reside with regulatory bodies overseeing device approvals and clinical validation protocols. Dependency risks include material shortages affecting production and evolving imaging standards. Switching costs are moderate due to specialized training required for interventional systems, with partnerships between OEMs and service providers ensuring interoperability. Ecosystem dynamics vary regionally based on healthcare infrastructure and reimbursement policies.

Recent Industry Insights

The Interventional Neuroradiology industry trends over the past 18 months reflect rapid innovation driven by technological advancements and strategic collaborations. Partnerships such as Stryker’s collaboration with an AI-driven imaging startup have enhanced procedural precision, while Mergers & acquisitions like Medtronic’s acquisition of a neurovascular device firm expanded therapeutic portfolios. Product/technology launches include Penumbra’s next-gen thrombectomy systems and Siemens Healthineers’ AI-integrated angiography platforms, addressing unmet needs in stroke treatment. Regulatory changes have accelerated, with the FDA clearing novel flow diverter stents and expanding approvals for embolic agents. A notable shift in enterprise trends sees hospitals prioritizing hybrid ORs to streamline complex neurointerventions. Funding rounds have surged, with startups securing $150M+ to develop robotics-assisted navigation tools, signaling confidence in digital transformation. Collectively, these developments underscore a market prioritizing precision, efficiency, and patient-centric care, positioning Interventional Neuroradiology for sustained growth through 2025.

Analyst Overview

The Interventional Neuroradiology market presents strong market attractiveness, driven by rising prevalence of cerebrovascular diseases and advancements in minimally invasive therapies. The sector demonstrates moderate competitive intensity, with established players dominating while fostering innovation through strategic R&D investments. The long-term outlook remains optimistic, underpinned by technological integration (e.g., AI-guided navigation) and expanding applications in complex neurovascular interventions. The innovation landscape is dynamic, focusing on precision therapies and hybrid operating rooms, though adoption rates vary by region. Demand–supply balance faces regional disparities, with high-income markets experiencing robust demand against constrained specialist availability. Key risk factors include regulatory scrutiny, reimbursement challenges, and procedural complexities. For stakeholders, the Interventional Neuroradiology market outlook highlights opportunities in emerging economies and digital health convergence, albeit with a need for balanced risk mitigation.

11 items

1. Executive Summary

2. Interventional Neuroradiology Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Interventional Neuroradiology Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Interventional Neuroradiology Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Ambulatory Surgical Centers

6.2. Global Interventional Neuroradiology Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Cerebral Aneurysms

6.2.2. Intra-Cranial Tumors

6.2.3. Acute Strokes

6.2.4. Other Diseases

6.3. Global Interventional Neuroradiology Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Interventional Neuroradiology Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Interventional Neuroradiology Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Interventional Neuroradiology Market Competition by Key Manufacturers

8.1. Global Interventional Neuroradiology Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Interventional Neuroradiology: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Balt Extrusion

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Merit Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Terumo

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Medtronic

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Penumbra

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Stryker

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. DePuy

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Boston Scientific

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. W. L. Gore

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. MicroPort

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Interventional Neuroradiology Market

Figure 4: Global Interventional Neuroradiology Market: Drivers

Figure 5: Global Interventional Neuroradiology Market: Challenges

Figure 6: Global Interventional Neuroradiology Market: Trends

Figure 7: Global Interventional Neuroradiology Market: Opportunity

Figure 8: Global Interventional Neuroradiology Market: Restraint

Figure 9: Global Interventional Neuroradiology Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Interventional Neuroradiology Market Value (USD Million) By Region

Figure 15: Global Interventional Neuroradiology Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Interventional Neuroradiology Market Value (USD Million) By Region

Figure 23: Global Interventional Neuroradiology Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Interventional Neuroradiology Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Interventional Neuroradiology Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Interventional Neuroradiology Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Interventional Neuroradiology Market Value (USD Million) By Region

Table 10: Global Interventional Neuroradiology Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Interventional Neuroradiology Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Interventional Neuroradiology Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Interventional Neuroradiology Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Balt Extrusion Basic Information And Sales Area

Table 31: Balt Extrusion. Products Portfolio

Table 32: Merit Medical Basic Information And Sales Area

Table 33: Merit Medical. Products Portfolio

Table 34: Terumo Basic Information And Sales Area

Table 35: Terumo. Products Portfolio

Table 36: Medtronic Basic Information And Sales Area

Table 37: Medtronic. Products Portfolio

Table 38: Penumbra Basic Information And Sales Area

Table 39: Penumbra. Products Portfolio

Table 40: Stryker Basic Information And Sales Area

Table 41: Stryker. Products Portfolio

Table 42: DePuy Basic Information And Sales Area

Table 43: DePuy. Products Portfolio

Table 44: Boston Scientific Basic Information And Sales Area

Table 45: Boston Scientific. Products Portfolio

Table 46: W. L. Gore Basic Information And Sales Area

Table 47: W. L. Gore. Products Portfolio

Table 48: MicroPort Basic Information And Sales Area

Table 49: MicroPort. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Interventional Neuroradiology Market Value (USD Million) By Region

Table 55: Global Interventional Neuroradiology Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Interventional Neuroradiology Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.80 billion
Revenue forecast in 2033	3.21 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Balt Extrusion; Merit Medical; Terumo; Medtronic; Penumbra; Stryker; DePuy; Boston Scientific; W. L. Gore; MicroPort
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High costs of advanced interventional devices and procedures limit accessibility, particularly in low- and middle-income countries, constraining Interventional Neuroradiology market expansion.

Stringent regulatory requirements for device approvals and clinical trials pose delays in market entry, increasing R&D costs for new therapies or equipment.

Opportunities2 items

Growing healthcare investments in emerging economies, coupled with telemedicine-enabled training programs, are unlocking untapped demand in the Interventional Neuroradiology market.

Challenges2 items

The technical complexity of procedures requires highly trained specialists, creating a shortage of skilled professionals and limiting market scalability.

Market Segmentation

Loading chart…

Interventional Neuroradiology Segmentation Breakdown8 items

Application

Hospital

Ambulatory Surgical Centers

Types

Cerebral Aneurysms

Intra-Cranial Tumors

Acute Strokes

Other Diseases

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: Advanced healthcare ecosystem, high procedural adoption, and R&D investments.

Europe: Regulatory harmonization, aging population, and cross-border medical collaboration.

Asia Pacific: Rising healthcare expenditure, urbanization, and disease prevalence.

Latin America: Infrastructure upgrades and growing neurology service accessibility.

Middle East & Africa: Government healthcare initiatives and urban economic expansion.

Competitive Landscape

Medtronic: Innovation pipeline in endovascular aneurysm repair devices

Stryker: Regional expansion through acquisitions in emerging markets

Boston Scientific: OEM tie-ups for neurovascular coil manufacturing

Terumo: Premium pricing for thrombectomy catheter systems

Penumbra: R&D partnerships for stroke treatment platforms

MicroPort: Local manufacturing to serve China’s neurointervention market

Key Interventional Neuroradiology Companies10 items

Balt Extrusion

Merit Medical

Terumo

Medtronic

Penumbra

Stryker

DePuy

Boston Scientific

W. L. Gore

MicroPort

Market Ecosystem

Raw material/component suppliers – supply polymers, metals, and imaging sensors for device fabrication

OEMs/Manufacturers – design and produce interventional catheters, guidewires, and imaging systems

Technology providers – develop AI-driven imaging algorithms and real-time navigation software

System integrators – customize equipment configurations for hospital radiology suites

Distributors/Channel partners – facilitate equipment and consumables procurement for clinical facilities

Service providers/After-sales – ensure device maintenance and regulatory compliance through calibration services

End users – neurointerventional radiologists perform procedures in acute stroke and aneurysm treatment

Recent Industry Insights

Analyst Overview

Table of Contents